• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    More On TOS.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    TSO3 Inc. (TOS.TO)

    -Toronto
    1.20 0.00(0.00%) Feb 27, 3:59PM EST
    Add to Portfolio
    ProfileGet Profile for:
    TSO3 Inc.
    2505, Avenue Dalton
    Quebec, QC G1P 3S5
    Canada - Map
    Phone: 418-651-0003
    Fax: 418-653-5726
    Website: http://www.tso3.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:34

    Business Summary 

    TSO3 Inc. is engaged in the research, development, commercialization, and licensing of sterilization processes, related consumable supplies, and accessories for heat-sensitive medical devices in Canada and internationally. Its products include Sterizone 125L+ sterilizer for the reprocessing of general instrumentation, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes; and 125L Ozone sterilizer for heat-and moisture-sensitive medical devices, such as general stainless steel instruments and rigid endoscopes. The company also offers 125-280 Solution, a 50% stabilized hydrogen peroxide; and develops STERIZONE 80L sterilizer that targets the need for a smaller device or sub-sterile in North America. In addition, it provides product development services to medical device manufacturers that include hydrogen peroxide and ozone sterilization validation, compatibility testing, medical devices cleaning method development, and medical packaging compatibility verification. The company was founded in 1998 and is headquartered in Quebec, Canada.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on TSO3 Inc.

    Key Executives 
     PayExercised
    Mr. Richard M. Rumble , 56
    Chief Exec. Officer, Pres, Director and Chairman of Advisory Committee
    379.00K0.00
    Dr. Beno Deschamps MBA, Ph.D., 63
    Chief Financial Officer, VP of Fin. and Sec.
    194.00K0.00
    Mrs. Paule De Blois M.B.A., C.H.R.P,
    Gen. Mang. of Admin.
    N/AN/A
    Ms. Caroline Cote ,
    Director of Investor and Bus. Relations
    N/AN/A
    Mr. Robert F. Mosher ,
    Vice-Pres of Global Marketing
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.